Celgene arthritis drug appears effective, safe after one year: study

By Bill Berkrot (Reuters) - Previously untreated patients experienced significant and lasting reductions in signs and symptoms of psoriatic arthritis when given Celgene Corp's experimental oral drug, apremilast, according to data from a late stage clinical trial. Patients taking either the 20 milligrams or 30 mg dose of apremilast twice a day had a statistically significant improvement in symptoms, such as painful, swollen joints, after 16 weeks of treatment compared with those who received a placebo, researchers said. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/celgene-arthritis-drug-appears-effective-safe-one-study-203611350--finance.html